Learn how ultrasensitive nanoparticle probes, covalent binding chemistry, and quantitative smartphonebased readers are inspiring an explosion in the use and potential of lateral flow diagnostics. These advances enable the detection of ultralow concentration biomarkers and are opening the door to the diagnosis of diseases and earlystage conditions previously undetectable by lateral flow.